title: Drugs ten years later: epirubicin.
authors.affiliation: Istituto Nazionale Tumori, Milan, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Bonadonna
authors.forename: L
authors.initials: L
authors.lastname: Gianni
authors.forename: A
authors.initials: A
authors.lastname: Santoro
authors.forename: V
authors.initials: V
authors.lastname: Bonfante
authors.forename: P
authors.initials: P
authors.lastname: Bidoli
authors.forename: P
authors.initials: P
authors.lastname: Casali
authors.forename: R
authors.initials: R
authors.lastname: Demicheli
authors.forename: P
authors.initials: P
authors.lastname: Valagussa
mesh_terms: D009202:Cardiomyopathies / Q000139:chemically induced; D015251:Epirubicin / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D015251:Epirubicin